Companies in the bioinformatics sector developing innovative solutions and technologies.
Explore 140 recently funded bioinformatics companies with verified founder contact information and fundraising data.
BIOMES is a biotechnological pioneer that specializes in improving everyones wellbeing by analyzing and interpreting the human microbiome.
PentaBind uses Generative AI and aptamers for innovative drug discovery and diagnostics in biotechnology.
Exty provides AI tools for personalized nutrition, fitness, and wellness guidance based on individual health data.
The James Hutton Institute delivers fundamental and applied science to drive the sustainable use of land and natural resources.
Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.
enGenome provides bioinformatics solutions for translational research and clinical routine.
NemaLife offers chemical testing services for the pharmaceuticals, biotechnology, agrochemicals, cannabis, and nutraceuticals sectors.
Delivers brain-inspired, auditable AI that learns in real time, runs on ultra-low compute, and cuts cost, latency, and power.
Developer of drug and risk analysis platform designed to generate causal hypotheses for drug efficacy and systemic toxicity.
Animal Agtech, Equipment, SaaS, HaaS, Digital Animal Health
Spren helps fitness and wellness brands deliver a more personalized, engaging, and effective user experience.
Clinical-Microbiomics is an independent contract research organization fully dedicated to microbiome research.
SOMOS is offering genetic solutions that put at your disposal tests of global ancestry and Latin American ancestry.
The bioinformatics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Bioinformatics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The bioinformatics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 140 bioinformatics companies tracked in the VCBacked database.
Companies in the bioinformatics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting bioinformatics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked